Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$359M Buy
2,974,102
+3,729
+0.1% +$431K 0.64% 24
2025
Q4
$313M Sell
2,970,373
-722,894
-20% -$67.9M 0.54% 29
2025
Q3
$290M Buy
3,693,267
+60,374
+2% +$4.97M 0.42% 36
2025
Q2
$288M Buy
3,632,893
+511,604
+16% +$40.7M 0.46% 34
2025
Q1
$280M Buy
3,121,289
+19,981
+0.6% +$1.87M 0.49% 34
2024
Q4
$308M Buy
3,101,308
+643,991
+26% +$66.4M 0.53% 30
2024
Q3
$279M Buy
2,457,317
+76,811
+3% +$9.13M 0.49% 34
2024
Q2
$295M Sell
2,380,506
-107,439
-4% -$13.8M 0.55% 32
2024
Q1
$329M Sell
2,487,945
-22,794
-0.9% -$2.81M 0.66% 23
2023
Q4
$272M Sell
2,510,739
-285,504
-10% -$29.6M 0.6% 28
2023
Q3
$288M Sell
2,796,243
-21,719
-0.8% -$2.34M 0.69% 26
2023
Q2
$327M Buy
2,817,962
+166,390
+6% +$18.9M 0.77% 20
2023
Q1
$282M Buy
2,651,572
+19,970
+0.8% +$2.16M 0.7% 23
2022
Q4
$293M Sell
2,631,602
-194,176
-7% -$19.8M 0.77% 20
2022
Q3
$243M Sell
2,825,778
-80,521
-3% -$7.19M 0.69% 20
2022
Q2
$266M Sell
2,906,299
-35,979
-1% -$3.19M 0.7% 22
2022
Q1
$254M Buy
2,942,278
+31,943
+1% +$2.52M 0.53% 33
2021
Q4
$223M Sell
2,910,335
-46,604
-2% -$3.71M 0.46% 40
2021
Q3
$224M Sell
2,956,939
-62,975
-2% -$4.79M 0.52% 36
2021
Q2
$235M Sell
3,019,914
-522,930
-15% -$38.9M 0.54% 35
2021
Q1
$259M Sell
3,542,844
-145,876
-4% -$10.8M 0.63% 27
2020
Q4
$287M Buy
3,688,720
+246,644
+7% +$18.9M 0.54% 35
2020
Q3
$272M Sell
3,442,076
-72,160
-2% -$5.65M 0.59% 31
2020
Q2
$258M Buy
3,514,236
+11,771
+0.3% +$886K 0.59% 30
2020
Q1
$259M Buy
3,502,465
+21,149
+0.6% +$1.66M 0.69% 29
2019
Q4
$300M Buy
3,481,316
+537,111
+18% +$44.1M 0.65% 32
2019
Q3
$237M Sell
2,944,205
-177,788
-6% -$14.2M 0.56% 40
2019
Q2
$250M Buy
3,121,993
+86,439
+3% +$6.62M 0.57% 36
2019
Q1
$240M Buy
3,035,554
+264,265
+10% +$19.8M 0.64% 33
2018
Q4
$195M Sell
2,771,289
-368,003
-12% -$26M 0.56% 41
2018
Q3
$213M Sell
3,139,292
-194,915
-6% -$12.4M 0.51% 44
2018
Q2
$193M Sell
3,334,207
-226,259
-6% -$12.8M 0.45% 50
2018
Q1
$185M Sell
3,560,466
-243,034
-6% -$13.1M 0.45% 50
2017
Q4
$204M Buy
3,803,500
+574,935
+18% +$31.9M 0.48% 47
2017
Q3
$198M Buy
3,228,565
+23,413
+0.7% +$1.42M 0.49% 43
2017
Q2
$196M Sell
3,205,152
-45,961
-1% -$2.8M 0.52% 44
2017
Q1
$197M Buy
3,251,113
+15,195
+0.5% +$922K 0.53% 41
2016
Q4
$182M Buy
3,235,918
+100,228
+3% +$5.87M 0.51% 41
2016
Q3
$187M Sell
3,135,690
-114,274
-4% -$6.68M 0.54% 39
2016
Q2
$178M Buy
3,249,964
+939,452
+41% +$50M 0.54% 41
2016
Q1
$117M Sell
2,310,512
-35,020
-1% -$1.72M 0.42% 58
2015
Q4
$118M Sell
2,345,532
-65,211
-3% -$3.29M 0.45% 54
2015
Q3
$114M Sell
2,410,743
-45,916
-2% -$2.44M 0.45% 55
2015
Q2
$133M Sell
2,456,659
-13,587
-0.6% -$762K 0.46% 47
2015
Q1
$135M Sell
2,470,246
-216,180
-8% -$12.2M 0.46% 44
2014
Q4
$145M Buy
2,686,426
+54,576
+2% +$3.04M 0.48% 47
2014
Q3
$149M Sell
2,631,850
-215,390
-8% -$12.1M 0.5% 42
2014
Q2
$157M Sell
2,847,240
-305
-0% -$16.6K 0.51% 41
2014
Q1
$153M Sell
2,847,545
-10,940
-0.4% -$566K 0.54% 40
2013
Q4
$137M Buy
2,858,485
+365,396
+15% +$16.7M 0.49% 39
2013
Q3
$113M Buy
2,493,089
+2,042,217
+453% +$93.2M 0.45% 49
2013
Q2
$20M Buy
+450,872
New +$20.1M 0.13% 141

Other funds holding MRK

Canada Life's MRK Position: Q1 2026 in Review

Canada Life increased its Merck (MRK) stake by 0.13% in Q1 2026, buying an estimated $431K and bringing the position to 2,974,102 shares worth $359M. The position accounts for 0.64% of the portfolio, ranked #24.

Canada Life first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Canada Life held 2,974,102 shares of Merck worth $359M as of Q1 2026.
  • Canada Life bought 3,729 Merck shares in Q1 2026, an estimated $431K.
  • Merck made up 0.64% of Canada Life's portfolio in Q1 2026, its #24 holding.
  • Canada Life first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.